XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.70

-0.8%

Jan 23 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (9374)	3/24/1999 11:28:00 PM
From: Bluegreen	Read Replies (1) of 17367

George, the difference is historically kids of all ages and various physical characteristics have succumbed to Meningo. if untreated with Neuprex. Didn't Only one kid in Phase II having Meningo. treated with Neuprex die with certain unusual characteristics? Now how could the DSMB project from Phase II if all kids without unusual characteristics survived?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next